CVBF vs FBK

CVBF presents a strong value opportunity, trading significantly below both its Graham Number ($24.06) and Intrinsic Value ($35.26). While the Piotroski F-Score of 4/9 indicates stable but not exceptional financial health, the company demonstrates exceptional operational consistency with a long history of earnings beats. The combination of a low forward P/E (10.69), a sustainable dividend yield of 3.85%, and positive earnings growth suggests a high margin of safety despite current bearish technical trends.

FBK presents a stark contrast between aggressive growth and deteriorating fundamental health, highlighted by a critical Piotroski F-Score of 2/9. While the company demonstrates impressive YoY revenue and earnings growth (~31%) and a consistent track record of earnings beats, the low health score and bearish insider sentiment are significant red flags. The stock currently trades at a premium to its Graham Number ($46.0) but remains below its growth-based intrinsic value ($72.28). The bullish analyst consensus is heavily countered by poor deterministic health metrics and a bearish technical trend.